180 related articles for article (PubMed ID: 26767517)
21. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
Karande P; Mitragotri S
Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
[TBL] [Abstract][Full Text] [Related]
22. 9-Phenanthrol enhances the generation of an CD8
Hartmann AK; Aranda Lopez P; Zajac M; Freichel M; Schild H; Radsak MP; Stassen M
J Dermatol Sci; 2017 Sep; 87(3):260-267. PubMed ID: 28823644
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice.
Hirobe S; Susai R; Takeuchi H; Eguchi R; Ito S; Quan YS; Kamiyama F; Okada N
Int J Pharm; 2021 May; 601():120563. PubMed ID: 33811967
[TBL] [Abstract][Full Text] [Related]
24. Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization.
Rattanapak T; Birchall JC; Young K; Kubo A; Fujimori S; Ishii M; Hook S
PLoS One; 2014; 9(2):e89503. PubMed ID: 24586830
[TBL] [Abstract][Full Text] [Related]
25. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM; Scharton-Kersten T; Vassell R; Matyas GR; Alving CR
Infect Immun; 1999 Mar; 67(3):1100-6. PubMed ID: 10024549
[TBL] [Abstract][Full Text] [Related]
26. Transcutaneous vaccination via laser microporation.
Weiss R; Hessenberger M; Kitzmüller S; Bach D; Weinberger EE; Krautgartner WD; Hauser-Kronberger C; Malissen B; Boehler C; Kalia YN; Thalhamer J; Scheiblhofer S
J Control Release; 2012 Sep; 162(2):391-9. PubMed ID: 22750193
[TBL] [Abstract][Full Text] [Related]
27. Transcutaneous immunization: T cell responses and boosting of existing immunity.
Hammond SA; Walwender D; Alving CR; Glenn GM
Vaccine; 2001 Mar; 19(17-19):2701-7. PubMed ID: 11257412
[TBL] [Abstract][Full Text] [Related]
28. Novel Biomimetic Reconstituted Built-in Adjuvanted Hepatitis B Vaccine for Transcutaneous Immunization.
Kaurav M; Kumar R; Jain A; Pandey RS
J Pharm Sci; 2019 Nov; 108(11):3550-3559. PubMed ID: 31348940
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive immunization on the skin using DNA vaccine.
Cui Z; Dierling A; Foldvari M
Curr Drug Deliv; 2006 Jan; 3(1):29-35. PubMed ID: 16472091
[TBL] [Abstract][Full Text] [Related]
30. Particle based vaccine formulations for transcutaneous immunization.
Mittal A; Raber AS; Lehr CM; Hansen S
Hum Vaccin Immunother; 2013 Sep; 9(9):1950-5. PubMed ID: 23778884
[TBL] [Abstract][Full Text] [Related]
31. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
[TBL] [Abstract][Full Text] [Related]
32. Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch.
Ito S; Hirobe S; Yamashita R; Sugiyama A; Takeuchi H; Eguchi R; Yoshida J; Oyamada T; Tachibana M; Okada N
Vaccine; 2022 Feb; 40(6):862-872. PubMed ID: 34998604
[TBL] [Abstract][Full Text] [Related]
33. Mucosal immune responses induced by transcutaneous vaccines.
Lawson LB; Clements JD; Freytag LC
Curr Top Microbiol Immunol; 2012; 354():19-37. PubMed ID: 22435116
[TBL] [Abstract][Full Text] [Related]
34. Colloidal carrier systems for transcutaneous immunization.
Gupta PN; Vyas SP
Curr Drug Targets; 2011 Apr; 12(4):579-97. PubMed ID: 21226670
[TBL] [Abstract][Full Text] [Related]
35. Solid-in-oil nanodispersions for transdermal drug delivery systems.
Kitaoka M; Wakabayashi R; Kamiya N; Goto M
Biotechnol J; 2016 Nov; 11(11):1375-1385. PubMed ID: 27529824
[TBL] [Abstract][Full Text] [Related]
36. Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.
Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
Int J Nanomedicine; 2011; 6():3241-50. PubMed ID: 22228992
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous immunization and immunostimulant strategies.
Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR
Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392
[TBL] [Abstract][Full Text] [Related]
38. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
[TBL] [Abstract][Full Text] [Related]
39. Immunization with DNA through the skin.
Peachman KK; Rao M; Alving CR
Methods; 2003 Nov; 31(3):232-42. PubMed ID: 14511956
[TBL] [Abstract][Full Text] [Related]
40. Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization.
Gogoll K; Stein P; Lee KD; Arnold P; Peters T; Schild H; Radsak M; Langguth P
Cell Immunol; 2016 Oct; 308():35-43. PubMed ID: 27318760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
